2.5 million doses of Moderna vaccine from the U.S. arrive in Pakistan

[ad_1]
Islamabad: Nearly 2.5 million doses of Moderna vaccine from the United States donated under the COVAX program arrived in Pakistan on Friday.
According to a statement from the U.S. Embassy, the donation is part of the 80 million doses of vaccines shared by the United States with the world, fulfilling its commitment to promote equitable access to safe and effective vaccines worldwide, which is critical to ending the COVID-19 pandemic.
“The US Mission in Pakistan is very happy to share these safe and effective vaccines with the Pakistani people,” said Angela P Aggeler, Chargé d’affaires of the US Embassy.
“These vaccines will save lives and help Pakistan get out of this crisis, which has destroyed many families and communities in our two countries. The vaccinated public will also help restore the economic and social interaction we all welcome. We are grateful. Continuous cooperation with the Pakistani government and our international partners to achieve this delivery and these goals.”
The statement added that in addition to today’s vaccine donation, the United States has also provided nearly $50 million in COVID-19 assistance through cooperation with the Pakistani government.
This is the first two doses of Moderna vaccine received by the county. This is the third non-Chinese vaccine currently available in Pakistan.
Earlier, British-made AstraZeneca and American-made Pfizer were vaccinated in the country along with China’s Sinopharm, Konowak and Kansino vaccines.
Since the Chinese vaccine has not been approved in many countries, the vaccine will also be used by those who wish to travel abroad.
Who should be vaccinated
- People over 18 years of age.
- Pregnant and lactating women.
- Those with comorbidities, such as diabetes, hypertension, congestive heart failure, renal failure, chronic liver disease, etc.
- Those who have recently experienced a mild COVID-19 episode can be vaccinated after the quarantine period is over.
- People with severe COVID-19 can be vaccinated once they are clinically stable.
- Those who are immunosuppressed for a long time may get the vaccine, but the effectiveness may be less
- After organ transplantation, patients can be vaccinated 3 months after the transplant operation.
- After chemotherapy, patients can be vaccinated 28 days after chemotherapy.
Who should not be vaccinated
- If you have a severe allergic reaction (allergic reaction) or an immediate allergic reaction, even if it is not serious:
- Any component of the mRNA COVID-19 vaccine (such as polyethylene glycol)
- Or after the first dose of vaccine, the second dose of mRNA COVID-19 vaccine should not be given.
- Pending further research results, it is not recommended for people under 18 years of age to be vaccinated.
- Generally speaking, people who have an immediate non-allergic allergic reaction to the first dose should not receive an additional dose unless recommended by a health professional with professional knowledge after review.
[ad_2]
Source link